Phagocytosis and antigen presentation

Seminars in Immunology

Volumn 13, Issue 6, 2001, Pages 373-379

  Watts, Colin ^a   Amigorena, Sebastian ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL MEMBRANE TRANSPORT; CYTOSOL; CYTOTOXICITY; DENDRITIC CELL; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0035209368     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.2001.0334     Document Type: Article

References (69)

1. Capture and processing of exogenous antigens for presentation on MHC molecules
2. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells
3. The major substrates for TAP in vivo are derived from newly synthesized proteins
4. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
5. Mechanisms of MHC class I-restricted antigen processing
6. Proteolysis and class I major histocompatibility complex antigen presentation
7. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER
8. MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum
9. The nature of the MHC class I peptide loading complex
10. Antigen processing in the endocytic compartment
11. Invariant chain structure and MHC class II function
12. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules
13. Nonclassical MHC class II molecules
14. The cell biology of antigen presentation in dendritic cells
15. Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing
16. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide: Class II MHC complexes
17. Two T cell epitopes from the M5 protein of viable streptococcus pyogenes engage different pathways of bacterial antigen processing in mouse macrophages
18. Phagocytosis of antigens by langerhans cells in vitro
19. New insights into the mobilization and phagocytic activity of dendritic cells
20. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
21. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes
22. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells
23. A life stage of particle-laden rat dendritic cells in vivo: Their terminal division, active phagocytosis, and translocation from the liver to the draining lymph
24. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
25. The induction of tolerance by dendritic cells that have captured apoptotic cells
26. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells
27. Pathways for lipid antigen presentation by CD1 molecules: Nowhere for intracellular pathogens to hide
28. Diversification of CD1 proteins: Sampling the lipid content of different cellular compartments
29. Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells
30. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
31. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
32. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation
33. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens
34. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
35. Efficient major histocompatibility, complex class I presentation of exogenous antigen upon phagocytosis by macrophages
36. A phagosome-to-cytoso pathway for exogenous antigens presented on MHC class I molecules
37. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages
38. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells
39. Dendritic cells are unique leukocyte populations which control the primary immune response
40. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3)
41. A receptor for phosphatidylserine-specific clearance of apoptotic cells
42. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium
43. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
44. Alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells
45. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
46. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response
47. Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells
48. Dendritic cells cross-present latency gene products from epstein-barr virus-transformed b cells and expand minor-reactive cd8(+) killer t cells
49. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines
50. Role of antigen-presenting cells in long-term antitumor response based on tumor-derived apoptotic body vaccination
51. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
52. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo
53. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes
54. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73
55. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
56. FcγR-mediated induction of dendritic cell maturation and MHC class I-restricted antigen presentation after immune complex internalization
57. Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells
58. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
59. Consequences of cell death: Exposure to necrotic minor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
60. Natural adjuvants: Endogenous activators of dendritic cells
61. Dendritic cell maturation is induced by mycoplasma infection bnt not by necrotic cells
62. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
63. A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes
64. Cutting edge: Intravenous soluble antigen is presented to cd4 t cells by cd8(-) dendritic cells, but cross-presented to cd8 t cells by cd8(+) dendritic cells
65. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo
66. Class 1 MHC presentation of exogenous antigens
67. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: Implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines
68. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
69. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells